Scripps Research
Scripps Research is a prominent independent, not-for-profit organization dedicated to advancing research in the biomedical sciences. Founded in 1924, the institute has gained international recognition for its significant contributions to health and science, particularly in developing new treatments for diseases such as cancer, rheumatoid arthritis, and hemophilia. With approximately 3,000 employees across its campuses in La Jolla, California, and Jupiter, Florida, Scripps Research is home to renowned scientists, including three Nobel laureates, who focus on groundbreaking discoveries. Additionally, the institute offers a highly regarded graduate program that awards PhD degrees in biology and chemistry, consistently ranking among the top ten programs in the nation.
Blackthorn Therapeutics
Series B in 2019
Blackthorn Therapeutics, based in South San Francisco, California, is a clinical-stage biopharmaceutical company focused on developing precision medicine for neurobehavioral disorders. Founded in 2013, the company utilizes a proprietary computational platform that integrates advances in computational and clinical neuroscience to better understand the relationship between brain function and behavior. By targeting dysfunctional brain circuits, Blackthorn aims to address longstanding challenges in drug discovery and development. The company’s approach involves identifying novel therapeutic targets, small molecule drug candidates, and biologically-based patient subgroups that are most likely to benefit from treatment, thereby enhancing the precision of therapeutic interventions in the central nervous system.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.